NVZMY:OTCMKTS
NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
68,21 USD
arrow_downward
-0,56%(-0,38) 1 d.
16. 10., 13:31:04 GMT-4 · USD
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre NVZMY…
Otvoriť
68,34 USD
Vysoká
68,72 USD
Nízka
68,00 USD
Trh. kap.
183,47 mld.
Priem. obj.
23,36 tis.
Objem
10,31 tis.
Max. za 52 týž.
75,26 USD
Min. za 52 týž.
49,90 USD
Beta
0,87
Akcie v obehu
414,56 mil.
Počet zamestnancov
11 tis.
Otvoriť
68,34 USD
Vysoká
68,72 USD
Nízka
68,00 USD
Trh. kap.
183,47 mld.
Priem. obj.
23,36 tis.
Objem
10,31 tis.
Max. za 52 týž.
75,26 USD
Min. za 52 týž.
49,90 USD
Beta
0,87
Akcie v obehu
414,56 mil.
Počet zamestnancov
11 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
ad-hoc-news.de
·
pred 1 dňom
Novonesis stock stands 1.27 percent below its 52-week high
Profil
Novonesis is a biotechnology company headquartered in Lyngby, Denmark. Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen.
The company develops enzymes, microbial cultures, and other biological products used in food and beverage production, household products, agriculture, and bioenergy.
The merger, first announced in December 2022, was the largest merger in history between two Danish companies. It would combine Novozymes' industrial-enzyme business with Chr. Hansen's microbial cultures and food-ingredient operations.
The company is publicly traded on Nasdaq Copenhagen and is part of the OMX Copenhagen 25 Index. The company's largest shareholder is Novo Holdings A/S, which is owned by the Novo Nordisk Foundation.
As of 2025, Novonesis has more than 11,000 employees and activities in over 45 countries. Wikipedia
Informácie o subjekte NOVONESIS NOVOZYMES B Unsponsored Denmark ADR
Generálny riaditeľEster Baiget
Zamestnanci11,1 tis.
Dátum založenia2000
Hlavné sídlo-
OdvetvieSpeciality chemicals